Mammone, G., Demeulenaere, O., McTaggart, E. S., Naulaerts, S., Albersen, M., Baldewijns, M., Wever, L. D., Clement, P. M., Loocke, P. V., Kinget, L., Debruyne, P. R., Laenen, A., Garg, A., Beuselinck, B. (2026). Optimal hour of immune checkpoint inhibitors (ICIs) administration in metastatic renal cell carcinoma (mRCC): The “Tic-Tac” study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.7_suppl.452